December 2020 - Page 13 of 32

ThursdayDec 17, 2020 1:33 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes it Easier to See the Invisible in Cancer Surgery

Imagin Medical Inc. is a surgical imaging company building a platform of technological products designed to improve endoscopic surgeries through adaptable equipment that makes it easier to see anomalies such as cancerous tumors The company’s initial product launch will focus on bladder cancers visible under blue light thanks to a dye on the market that currently depends on the acquisition of expensive new equipment by hospitals Imagin’s proprietary i/Blue Imaging (TM) System resolves some of the expense and flexibility concerns expressed by urologists, which will grant surgeons the capacity to better root out cancers Imagin has announced an offering of…

ThursdayDec 17, 2020 1:09 pm

Predictive Oncology (NASDAQ: POAI) Leverages Precision Medicine Expertise to Support Oncologists, Improve Patient Outcomes

Precision medicine is emerging approach to disease prevention, treatment that incorporates individual’s distinctive characteristics. New approach allows doctors, researchers to predict more accurately which treatments may work better. Helomics’ database, largest of its kind, is comprised of ovarian, head and neck, colon and pancreas tumors. Science has discovered that thumbprints and DNA aren’t the only biological elements that make individuals unique. In fact, ears, eyes, tongues and even the way a person walks is distinctive, unlike anybody else in the world (https://ibn.fm/SJX27). Moreover, the things that make people different from each other don’t stop at physical characteristics. Predictive Oncology (NASDAQ:…

ThursdayDec 17, 2020 12:16 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Announces NeuroCap for Children, Enters Pediatric Market

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched its next-generation, disposable EEG cap, NeuroCap(TM) in a children’s size, making the innovative product available for use in the U.S. pediatric market. The smaller NeuroCap headset is designed to overcome common challenges that arise when conducting an electroencephalogram (“EEG”), such as measuring and marking the patient’s head, and following sanitation protocols. The pediatric NeuroCap also addresses the need for comfort, speed and reliability within the pediatric population. BRSF’s disposable, pre-gelled NeuroCap features 19 active EEG channels and 22 electrodes and can be quickly, easily and accurately applied by any…

ThursdayDec 17, 2020 11:28 am

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) to ‘Launch into 2021 with Various Exciting Projects’

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced an update for its first successful 100-acre pilot outdoor hemp CBD harvest. According to the update, the harvest yielded a quality much higher than the company’s expectations, and a yield of over 105,000 lbs in total biomass was prepared for sale and processing to Speakeasy Cannabis Club (CSE: EASY). "We are very proud of our team and partners at Rock Creek Farms who have been committed to the vision and dedicated to achieving success," said Pac Roots president and…

ThursdayDec 17, 2020 11:21 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) to Showcase Exclusive CBD-Infused CaniSun Suncare Line at Surf Expo 2021

Jupiter Wellness (NASDAQ: JUPW), a leading developer of innovative skin-care products, lotions, medical therapeutics and wellness products, will kick off the new year by participating in Surf Expo 2021, the largest watersport, beach and resort lifestyle tradeshow in the world. Scheduled for Jan. 6–8, 2021, Surf Expo 2021 will be held at the Orange County Convention Center in Orlando, Florida. More than 28,000 buyers attend the gathering every year; the buyers represent specialty stores, major chains, resorts, cruise lines, marinas and beach-rental companies from the United States, the Caribbean, and Central and South America. Jupiter Wellness will be displaying its…

ThursdayDec 17, 2020 10:48 am

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams declaring pivotal new insights into COVID-19 biology and disease processes. According to the update, all teams selected PBI's Pressure Cycling Technology ("PCT") platform for critical sample preparation steps to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in affected biochemical pathways. "The compelling history of scientists worldwide publishing on PBI's PCT-based Barocycler system…

ThursdayDec 17, 2020 10:42 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Proprietary Systems to be Utilized at Leading Specialty, Emergency Veterinary Care Hospitals

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, has finalized agreements to place its exclusive MiQLab(TM) systems at two specialty and emergency veterinary hospitals as part of the company’s Early Access Program (“EAP”); the company anticipates placing the systems in early 2021. The two practices are Veterinary Specialty Hospital (“VSH”) of Palm Beach Gardens, Florida, and Denver Animal Emergency in Denver, North Carolina. According to the agreement, the two leading hospitals will evaluate MiQLab-generated data, which is generated quickly, against traditional culture and sensitivity testing, which can take up to five days…

ThursdayDec 17, 2020 10:19 am

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Grows Distribution of Nation’s Fastest-Growing Closed System Vaping Product

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced that its Bidi(R) Stick is the fastest-growing closed system vaping product in the United States. KAVL is he exclusive global distributor of products manufactured by Bidi Vapor LLC, including the Bidi Stick. The company recently unveiled its latest offering, a tobacco-free nicotine pouch called Bidi(TM) Pouch. Kaival Brands has focused on growing the distribution of Bidi Stick products this year. For example, the company expects that, by the end of 2020, Bidi Sticks will be in more…

ThursdayDec 17, 2020 9:51 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) Eyes Opportunity in New Canadian Hydrogen Framework

Clean Power (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) today announced that it is encouraged by and applauds Canada's Federal Government and Canada's Minister of Natural Resources for the Dec. 16, 2020, launch of the country’s hydrogen strategy*. The strategy paves the way towards realizing Canada’s goal of carbon neutrality by 2050. “We are thrilled by the ambitious plans laid out in the Hydrogen Strategy for Canada. This strategy sets to make Canada a global leader in hydrogen by 2050, with up to 30% of Canada's energy to be hydrogen-based and a plan to build a national hydrogen fueling station network,”…

ThursdayDec 17, 2020 9:17 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval of IND Application for Brain Cancer Drug Candidate Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, this morning announced that it has received US Food and Drug Administration (“FDA”) approval of its Investigational New Drug (“IND”) application on its lead product candidate Berubicin for the treatment of Glioblastoma Multiforme (“GBM”). This approval signifies a crucial step for the company in launching a potentially pivotal trial to investigate the efficacy of Berubicin in adults with GBM who have been unsuccessful with first-line therapy. In addition, following recent correspondence with the FDA, the…

Site Search

Company Search

Month: December 2020